Blog

Certain Cannabinoids may be Effective Co-Therapies for Neuropathic or MS pain

In a systematic review of studies investigating cannabis therapy for the treatment of chronic non-cancer pain (CNCP), evidence pointed to cannabinoids primarily effecting change with respect to neuropathy or MS-related pain. For CNCPs, it is unlikely that cannabinoids can be used as a single therapy, but rather in conjunction with other therapies. The quality of evidence in many of the studies reviewed was low, so further research needs to be completed in order to evaluate the efficacy of cannabinoids as a long-term treatment option for CNCPs.

Read more here:

This paper is stored here: http://bit.ly/2IgOLiG inside the CED Foundation Archive To explore related literature, click keywords below:

Benjamin Caplan, MDCertain Cannabinoids may be Effective Co-Therapies for Neuropathic or MS pain

Related Posts